Biotech Specialty Pharma

Cancer Genetics

201 Route 17 North
Rutherford,, NJ 07070 USA
Click for website

Research Sector Biotech Specialty Pharma

Summary Description DNA-based cancer diagnostics of hematological, urogenital and HPV-associated cancers.

Management Panna Sharma, President and Chief Executive Officer; Elizabeth Czerepak, Chief Financial Officer; Jane Houldsworth, Ph.D., Vice President of Research and Development; Lan Wang, M.D., Medical Director; Weiyi Chen, Ph.D., HCLD (ABB), Molecular Diagnostics Director; Pal Singh-Kahlon, Ph.D., FACMG, Cytogenetics Director; Cory Hickmon, Director of National Clinical Sales

Click here for Financial Data
Keywords: Oncology, Hematological Cancer, Urogenital Cancer, HPV, DNA-Based Diagnosis, DNA, cancer, urology


Updated: Aug. 24, 2018


Cancer Genetics, Inc. is an emerging leader in DNA-based cancer diagnostics that personalizes the clinical management of difficult-to-diagnose cancers. These cancers include hematological, urogenital ......view more

Products / Services

Products being developed at CGI are poised to transform cancer patient management, increase treatment efficacy, and reduce healthcare costs. CGI has developed genomic products that are being used in t......view more

Technology / Differentiation

DNA-FISH Probes Fluorescent in situ hybridization (FISH) is a sensitive and accurate technique that allows the detection of chromosome aberrations. In this method, a single-stranded fluorescent-label...view more